Users Coming Off Weight-Loss Jabs Regain Pounds Far More Rapidly Compared to Those on Conventional Diets

A recent study indicates that patients who come off popular weight-loss injections like semaglutide or tirzepatide may regain reduced body mass at a significantly accelerated pace than those who stop traditional diet and exercise regimens.

Published data in a prominent medical journal shows that while overweight individuals can lose about a fifth of their total mass while undergoing treatment, the mass comes back at an average rate of 0.8 kg per month once they quit.

"People purchasing these drugs need to be aware of the potential of fast rebound weight gain when the treatment is stopped," cautioned lead investigator Dr. Susan Jebb.

That rate of recovery means a return to pre-treatment weight within about a year and a half.

Weighing Approaches

The study, which reviewed dozens of studies involving over 9,000 of participants, compared the outcomes of these new drugs with older methods.

The team point out that people who lose weight through lifestyle changes alone typically experience a more gradual weight regain—around 0.1 kg a month—after stopping.

The Reason for the Rapid Regain

Experts suggest the mechanism of the jabs explains the heightened rebound.

These medications copy a natural hormone called GLP-1, which helps regulate appetite.

"Artificially providing GLP-1 levels several times higher than the body's typical production could lead to the system to generate a reduced amount of its own natural GLP-1, and could reduce sensitivity to its actions," noted Dr. Adam Collins, a dietetics researcher.

"Stopping of this hormone supplement results in hunger is unsuppressed, making binge eating much more probable."

An Ongoing Issue?

Health authorities suggest the jabs for people with obesity-related medical conditions, accompanied by prescribed diet and exercise modifications.

A number of clinicians contend that, given the significant potential of relapse, the therapy is often ongoing.

This perspective is supported by pharmaceutical companies, who note that the findings "highlight the long-term nature of excess weight," comparing it to managing conditions like high blood pressure.

User Accounts

Individuals who have come off the medication report a sudden resurgence of hunger.

"It was like a trigger that goes on and I was suddenly ravenous," recalled an individual.

This difficulty is exacerbated if patients have not developed permanent dietary or behavioural modifications during therapy.

Significant Interest

Recent estimates indicate that a significant number of people in the UK have tried these injections in the last 12 months, with demand remaining high.

• Use is more common among women compared to men.
• The 40s and 50s demographic shows the greatest level of interest.
• A large proportion access the drugs through private prescriptions rather than public health services.

Finally, clinicians emphasize that while these medications are effective agents for shedding pounds, they are not a magic cure and lasting health benefits likely depends on combined behavioural changes.